Gentian Diagnostics ASA (OSL:GENT)
39.70
0.00 (0.00%)
Aug 26, 2026, 4:25 PM CET
Gentian Diagnostics ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8.41 | 13.26 | 45.29 | -10.65 | -23.62 | -24.79 |
Depreciation & Amortization | 6.87 | 6.94 | 6.69 | 6.49 | 6.36 | 4.96 |
Other Amortization | 2.18 | 2.18 | 2.27 | 3.08 | 3.88 | 2.4 |
Asset Writedown & Restructuring Costs | 30.24 | - | - | 6.47 | - | - |
Other Operating Activities | 3.39 | 12.41 | -25.23 | -0.61 | - | - |
Change in Accounts Receivable | -7.13 | 9.5 | -11.72 | -1.2 | -3.55 | 1.12 |
Change in Inventory | -1.84 | -8.2 | -8.83 | 2.69 | -8.77 | -8.9 |
Change in Accounts Payable | -2.26 | -4.09 | 2.84 | -0.88 | -0.53 | -0.83 |
Change in Other Net Operating Assets | -2.92 | 10.6 | 2.14 | 10.06 | 12.27 | -0.99 |
Operating Cash Flow | 19.28 | 42.59 | 13.46 | 15.46 | -13.95 | -27.05 |
Operating Cash Flow Growth | -3.09% | 216.49% | -12.95% | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.01 | -1.21 | -1.38 | -0.96 | -8.64 | -1.02 |
Sale (Purchase) of Intangibles | -5.39 | -9.55 | -9.57 | -3.53 | -6.03 | -11.79 |
Investment in Securities | - | - | - | -0.39 | - | - |
Investing Cash Flow | -6.39 | -10.76 | -10.95 | -4.88 | -14.67 | -12.82 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -4.96 | -4.95 | -4.6 | -4.33 | -3.69 |
Total Debt Repaid | -4.99 | -4.96 | -4.95 | -4.6 | -4.33 | -3.69 |
Net Debt Issued (Repaid) | -4.99 | -4.96 | -4.95 | -4.6 | -4.33 | -3.69 |
Issuance of Common Stock | 1.18 | - | - | - | - | 0.57 |
Common Dividends Paid | -9.28 | -6.17 | - | - | - | - |
Other Financing Activities | -0 | - | - | - | - | - |
Financing Cash Flow | -13.08 | -11.13 | -4.95 | -4.6 | -4.33 | -3.12 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.71 | 0.49 | -0.46 | 0.06 | -0.4 | -0.06 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | 0 | - |
Net Cash Flow | -0.91 | 21.19 | -2.9 | 6.04 | -33.34 | -43.05 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 18.27 | 41.38 | 12.08 | 14.5 | -22.59 | -28.08 |
Free Cash Flow Growth | -5.18% | 242.57% | -16.71% | - | - | - |
Free Cash Flow Margin | 10.03% | 23.45% | 7.94% | 10.73% | -20.18% | -28.07% |
Free Cash Flow Per Share | 1.18 | 2.67 | 0.77 | 0.94 | -1.47 | -1.82 |
Levered Free Cash Flow | 1.44 | 21.8 | -8.82 | 6.27 | -21.89 | -32.19 |
Unlevered Free Cash Flow | 1.94 | 22.22 | -8.41 | 6.76 | -21.11 | -31.32 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | -14.14 | 7.81 | -15.57 | 10.68 | -0.58 | -9.61 |